The global biopharmaceutical market saw a 2% increase in market capitalization in Q3 2024, led by growth from Bristol-Myers ...
Roche’s market capitalisation growth of 13.8% was driven by FDA approvals for two key products in September 2024: Ocrevus ...
TG Therapeutics, Inc. reported a modest Q3 beat and raised the full-year net sales guidance range for Briumvi by $7.5 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback